Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer

Endometrial adenocarcinoma is the most common gynecologic malignancy in the United States. However, reliable diagnostic or prognostic tumor markers have not been identified for endometrial cancer. In this study, we examined whether urokinase plasminogen activator receptor (UPAR), a glycosyl-phosphat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Memarzadeh, Sanaz, Kozak, Katherine R., Chang, Lisbeth, Natarajan, Sathima, Shintaku, Peter, Reddy, Srinivasa T., Farias-Eisner, Robin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Academy of Sciences 2002
Konular:
Biological Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC125001/
https://ncbi.nlm.nih.gov/pubmed/12130664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.152127499
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller